Invention Grant
- Patent Title: Pharmaceutical formulation comprising crystalline insulin and dissolved insulin
- Patent Title (中): 包含结晶胰岛素和溶解胰岛素的药物制剂
-
Application No.: US11664407Application Date: 2005-10-05
-
Publication No.: US07884181B2Publication Date: 2011-02-08
- Inventor: Petter Lybeck (Berglund) , Charlotte Hammelev , Lone Eskildsen , Johanne Madsen , Helle Aalund Olsen , Lone Kimer
- Applicant: Petter Lybeck (Berglund) , Charlotte Hammelev , Lone Eskildsen , Johanne Madsen , Helle Aalund Olsen , Lone Kimer
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Rosemarie R. Wilk-Orescan
- Priority: DK200401519 20041005
- International Application: PCT/EP2005/055017 WO 20051005
- International Announcement: WO2006/037784 WO 20060413
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The invention provides a pharmaceutical formulation and a method for preparing the formulation.
Public/Granted literature
- US20080171694A1 Pharmaceutical Formulation Comprising Crystalline Insulin and Dissolved Insulin Public/Granted day:2008-07-17
Information query
IPC分类:
